# Madrigal (MDGL) — Overview

MDGL · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mdgl

## Price

Last close $459.81 on Oct 15, 2026. 52-week range $412.35 – $602.83.

## Company profile

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $1.3B |
| Revenue (quarter) | $364.3M |
| Revenue growth (year over year) | 71.17% |
| Gross profit (trailing twelve months) | $1.2B |
| Gross margin | 91.48% |
| Net income (trailing twelve months) | −$325.1M |
| Net income (quarter) | −$57.9M |
| Net income growth (year over year) | -37.03% |
| Net margin | -25.32% |
| Return on equity | -53.31% |
| EPS (trailing twelve months) | −$13.99 |
| Book value per share | $22.68 |
| P/E (trailing twelve months) | — |
| Price to book | 20.3 |
| Debt to assets | 57.92% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Madrigal (MDGL) profitable?

No. Madrigal reported a net loss of $325.1M over the trailing twelve months.

### How much revenue does Madrigal (MDGL) make?

Madrigal generated $1.3B in revenue over the trailing twelve months, up 71.17% year over year.

### How do I buy stock in Madrigal (MDGL)?

MDGL trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).